Enjuvia and Savella drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among people who take Enjuvia and Savella. Common interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people who take Enjuvia and Savella have. It is created by eHealthMe based on reports of 19 people who take Enjuvia and Savella from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 17, 2022

19 people who take Enjuvia and Savella together, and have interactions are studied.

What is Enjuvia?

Enjuvia has active ingredients of estrogens, conjugated synthetic b. It is often used in hormone replacement therapy. eHealthMe is studying from 424 Enjuvia users for its effectiveness, alternative drugs and more.

What is Savella?

Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 6,993 Savella users for its effectiveness, alternative drugs and more.

Number of Enjuvia and Savella reports submitted per year:

Enjuvia and Savella drug interactions.

Common Enjuvia and Savella drug interactions by gender *:


  1. Anxiety
  2. Back pain
  3. Systemic lupus erythematosus
  4. Vitamin d deficiency
  5. Asthenia
  6. Disturbance in attention
  7. Memory impairment
  8. Tremor
  9. Blood glucose increased
  10. Bronchitis



Common Enjuvia and Savella drug interactions by age *:














  1. Vomiting
  2. Abdominal pain upper
  3. Headache
  4. Nasopharyngitis


  1. Abdominal pain upper
  2. Asthenia
  3. Disturbance in attention
  4. Memory impairment
  5. Tremor
  6. Blood glucose increased
  7. Hypoglycaemia

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 63.16%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 10.53%
  3. Immunodeficiency Common Variable: 2 people, 10.53%
  4. Type 2 Diabetes: 1 person, 5.26%
  5. Migraine (headache): 1 person, 5.26%
  6. Depression: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Enjuvia and Savella?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Enjuvia and Savella:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Savella interactions:

Browse all interactions between Savella and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estrogens, conjugated synthetic b and milnacipran hydrochloride (the active ingredients of Enjuvia and Savella, respectively), and Enjuvia and Savella (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Enjuvia and Savella.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: